Exploratory Study of Selected Stakeholder Insights Into Continuous Glucose Monitoring in T2D With Risk-Sharing Agreements

Recent trends toward payment reform in the care of chronic conditions seek to mitigate quality-related barriers to optimal diabetes management. In type 2 diabetes (T2D) management, these risk-sharing agreements are intended to improve clinical outcomes by facilitating care coordination, data reporting, and the implementation of interventions to address social determinants of health. Outside a need for systems reform, optimal diabetes management may be impeded by the underutilization of advances in care interventions, including continuous glucose monitoring (CGM). An influx of recent evidence and expert recommendations has expanded the utilization of CGM in the population with insulin-treated T2D. Considering recent evidence and guideline recommendations, a small expert panel of payer and provider stakeholders-with specific knowledge in diabetes disease management and risk-based agreements-was selected for this exploratory study to discuss opportunities for CGM-based care management in risk-sharing agreements between payers and providers. The panelists were surveyed before 2 virtual roundtable meetings in which pertinent clinical and trend data were shared. A moderated discussion allowed the expert panelists to outline key elements of potential risk-sharing agreements from the perspective of agreement design, realistic outcomes measures, and strategies to facilitate payer and provider participation.